Skip to main content

Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’ Access to Procedural Expertise

Innovative, cloud-based digital platform supports Urologists’ access to enhanced training with the UroLift® System through remote collaboration tools

WAYNE, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it is combining its leading industry clinical education with the digital platform of Explorer Surgical, a GHX company. This collaboration will provide Urologists expanded access to interactive training and remote learning opportunities for the Teleflex UroLift® System. 

The Explorer Live cloud-based digital platform communicates critical information through an interactive digital playbook, enabling surgical teams to access customized information for specific team roles. The platform facilitates UroLift System trainer collaboration with Urology surgical teams during live procedures from anywhere in the country through remote video connectivity. 

“Our clinical teams are able to reinforce the best practices and techniques for the UroLift System, and ultimately help clinicians become more proficient with the device so they can achieve better patient outcomes,” said Kevin Hardage, President and General Manager of Interventional Urology at Teleflex. “This innovative platform makes it easy for us to provide support where and when it is needed.”

“We have seen a tremendous response to Explorer Live from both our teams out in the field and the medical community they serve. And we are excited to offer physicians high quality remote learning opportunities that can increase BPH patient access to effective treatment with the UroLift System,” said Dale Zunke, Director of Clinical Affairs at Teleflex.

“We are pleased to support Teleflex in its commitment to achieving the best outcomes for patients,” said Jennifer Fried, general manager, Explorer Surgical, a GHX company. “This is an exciting opportunity for us to showcase how useful the platform can be in the urology specialty and demonstrate the need for innovative workflow and case support tools.”

With Explorer Live, all the processes and workflows of the UroLift System procedure are accessible before a surgical team performs any procedure. Through the platform, surgeons can:

  • Access images, PDFs, and videos about the UroLift System, surgical techniques, and a step-by-step workflow for each team member. The digital playbook is customized to the clinical team’s role, procedure type, and surgeon preferences. 
  • Broadcast in real-time to provide clinical education, remote collaboration, or demonstrations.
  • Capture robust video and procedural data to be used by the surgeon or in partnership with a medical device company for performance tracking, identifying opportunities to reduce variability, post-market feedback and analysis, and future product development.   

The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). It can result in rapid relief and recovery for men living with symptoms of an enlarged prostate,1 and provides an alternative therapy with a risk profile better than reported for surgical procedures such as TURP.2 The UroLift permanent implants are delivered during an outpatient procedure and relieve prostate obstruction without cutting, heating, or removing prostate tissue. 

For more information on UroLift, visit urolift.com. To learn more about Explorer Live, visit explorersurgical.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

About Teleflex Interventional Urology
The Teleflex Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive, and clinically effective devices that address unmet needs in the field of urology. Our focus is on improving the standard of care for patients with BPH using the UroLift® System, a minimally invasive, permanent implant system that treats symptoms while preserving sexual function. *1,3,4 Learn more at urolift.com.

Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose.

About Explorer Surgical
Explorer Surgical is dedicated to relentlessly innovating and developing scalable digital technologies to put best practices in the hands of all procedural teams. As a leader in creating state-of-the-art solutions, our cutting-edge, cloud-based, digital platform empowers medical device companies to disseminate procedural best practices and remotely connect with providers in real-time. Our goal is to demystify the black box of the operating room with an on-demand procedure playbook, real-time video collaboration and performance tracking tools to support medical device companies, accelerate product adoption, reinforce techniques, and support successful outcomes. 

Founded in 2015, Explorer Surgical started as a research project at the University of Chicago Medical Center in the Department of Surgery by Jennifer Fried and Dr. Alex Langerman. Dr. Langerman is a speaker and author on surgical ethics, video and data recording in the operating room, operating room efficiency, and clinical care of head and neck cancer patients. Today, the company has a global reach and has several customers, including some of the world’s top 10 largest medical device companies. The company was recently acquired by Global Healthcare Exchange, LLC (GHX) and now operates as a wholly owned subsidiary of GHX.

For more information or to schedule a demo of Explorer Live’s platform, visit explorersurgical.com or follow us on LinkedIn.

Contacts
Teleflex Incorporated: 
Lawrence Keusch 
Vice President, Investor Relations and Strategy Development 
 
John Hsu, CFA 
Vice President, Investor Relations 
investors.teleflex.com
610.948.2836 
 
Media
Nicole Osmer, 650.454.0504 
nicole@healthandcommerce.com 

References

* No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.

  1. Roehrborn, J Urol 2013
  2. Sonksen, Eur Urol 2015
  3. AUA BPH Guidelines 2003, 2020
  4. McVary, J Sex Med 2016

Teleflex, the Teleflex logo, NeoTract, the NeoTract logo and UroLift are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

MAC002247-01 Rev A

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.